Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · IEX Real-Time Price · USD
48.38
+0.36 (0.75%)
At close: Jul 19, 2024, 4:00 PM
48.35
-0.03 (-0.06%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $1.75 billion as of July 22, 2024. Its market cap has increased by 51.38% in one year.
Market Cap
1.75B
Enterprise Value
1.32B
1-Year Change
51.38%
Ranking
Category
Stock Price
$48.38
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has increased from $365.20M to $1.75B, an increase of 378.02%. That is a compound annual growth rate of 44.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 1.75B | 46.55% |
| Dec 29, 2023 | 1.19B | -9.93% |
| Dec 30, 2022 | 1.32B | -3.40% |
| Dec 31, 2021 | 1.37B | -3.86% |
| Dec 31, 2020 | 1.42B | 289.95% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RxSight | 1.82B |
| Harmony Biosciences Holdings | 1.82B |
| Neumora Therapeutics | 1.80B |
| Ligand Pharmaceuticals | 1.79B |
| Veracyte | 1.77B |
| Galapagos NV | 1.72B |
| Soleno Therapeutics | 1.71B |
| NewAmsterdam Pharma Company | 1.70B |